BioCardia, Inc.BCDANASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P7
Near historical low
vs 5Y Ago
-33.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-43.22%
2023-12.54%
20223.23%
2021-12.75%
202014.56%
20191.29%
201845.77%
201774.14%
2016119.37%
2015-0.33%